Skip to main content

Micro mobility Providing First and Last Mile Connectivity for Commuters

Technological innovation in the transportation industry encompasses a comprehensive range of mobility methods delivering a broad range of products to the industry. Modern day's consumer is well-connected and well-informed, and as a result, this is leading the major operating players to research, develop, and technologically evolve continuously to safeguard their position in the ecosystem. Transportation system regulations are primarily designed around demographic needs based on the government policy framework. Some of the essential criteria which are taken into consideration while creating a policy regulation for a specific region are- the socio-economic conditions, commuter lifestyle, degree of technology acceptance, demographic terms, infrastructure availability, and global economic conditions. 

Mobility as a service (MaaS) providers have established a strong foundation for the development shared mobility ecosystem, which has the potential to ensure high resource utilization rate unlike the conventional method of personal vehicle ownership model. The foundation also leads to an essential fact that there are gaps in MaaS and end-to-end connectivity; and here, micro mobility performs as a bridge between shared services and their end-to-end connectivity. Micro mobility service is the efficient use of light, compact, and swift modes of commute majorly powered by human or electric. The micro mobility as a service came into existence in China, driven by Mobike – a bicycle-based ride shares service providers.

For the Report Sample, Click Here:https://bisresearch.com/requestsample?id=745&type=download

The micro mobility technologies have currently witnessed a sudden upsurge due to many factors, some of which are detailed below:

  • The reduction in cost of mode procurement
  • Growth in technical capability and advance design skills which enabled development of efficient products which could contribute to conservation environment.

Micro mobility modes offer large degree of flexibility of driving on roads, footpaths or dedicated tracks built along with the road network in a city. The road network in the developed nations constitutes of a planned layout with dedicated cycle tracks (that can be used for similar types of vehicles) and footpaths. However, the usage of various modes on different locations is subject to the design and application of each mode. Commercial micro mobility market majorly utilizes road network as it accounts for faster moving vehicles such as motorcycles, mopeds, e-bikes, e-mopeds, and micro electric cars, among others.

Due to certain advancements in technology, the overall cost of the micro-mobility modes such as e-scooters, e-bikes, bicycles, and e-mopeds dropped drastically during the past five-year period between 2013-2018. The option of end-to-end connectivity via these low-cost modes is a lucrative option for the service provider as well as the consumer. These factors reduce the initial cost of investment for the company and enable them to offer a low-cost travel mode in the form of micro-mobility to the end-users. The mobility ecosystem has witnessed the proliferation of electric vehicles and personal portable devices extensively in shared mobility services.

Read Report Overview: https://bisresearch.com/industry-report/micro-mobility-market.html


Labels:

Comments

Post a Comment

Popular posts from this blog

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

  Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing   microbiome therapeutics market    is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...
Post a Comment
Read more

PD-1/PDL-1 Inhibitor Market Growth Prospects, Emerging Trends and Forecast to 2032

  PD-1/PDL-1 inhibitors are immune-therapeutic agents used in the treatment of various cancer indications, mostly in the advanced stages. PD-1/PDL-1 inhibitors are monoclonal antibodies majorly of IgG1 and IgG4 types to be administered to patients via injection The current market already has seven approved products in the U.S. and a large number of research activities are currently undergoing in this segment generating interest of commercial as well as academic research institutions. In the current period of precision medicine and providing targeted treatment, identification of target patient has become very important as well as complicated. With the emergence of diagnostic test identifying predictive biomarkers, the selection and administration of targeted treatment has become comparativlely conveninent and efficient. PD-1/PDL-1 inhibitors market   are majorly indicated for the treatment of advanced cases of different cancer indications. The PD-1/PDL-1 inibitor treatment has ...
Post a Comment
Read more

Clinical Decision Support Systems (CDSS) Market registering a CAGR of 6.70% during the forecast period 2021-2030

The global market for clinical decision support systems (CDSS) registered the market value of $1,918.8 million in 2020 and is expected to reach $3,739.2 million by 2030, registering at a CAGR of 6.70% during the forecast period 2020-2030. The clinical decision support systems of the future are expected to be developed to leverage data to make observations which are not interpretable by humans. Healthcare IT systems in the future are expected to leverage cutting-edge technology as an enabler to make clinical care more streamlined and accurate. The technology is still in its nascent stage. One of the strong points of this technology is that it improves with time. Continuous input from clinicians, patients, and other stakeholders will be essential for correctly implementing the technology to enhance meaningful uses, reduce costs, and improve treatment outcomes. Key USPs of the Report Following are some of the key contents of the report: •     Industry Analysis    ...
Post a Comment
Read more